Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative Colitis

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

April 1, 2024

Study Completion Date

October 1, 2024

Conditions
Ulcerative Colitis
Interventions
DIAGNOSTIC_TEST

Intestinal ultrasound

Ulcerative colitis patients treated with filgotinib will undergo intestinal transabdominal ultrasound at baseline, week 4 and at the time of the follow-up endoscopy (week 10-16)

Trial Locations (1)

1105AZ

Amsterdam UMC, Amsterdam-Zuidoost

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Galapagos NV

INDUSTRY

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT05653791 - Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative Colitis | Biotech Hunter | Biotech Hunter